Works matching IS 08971900 AND DT 2018 AND VI 31 AND IP 5


Results: 19
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14

    Development of Glatopa® (Glatiramer Acetate): The First FDA-Approved Generic Disease-Modifying Therapy for Relapsing Forms of Multiple Sclerosis.

    Published in:
    Journal of Pharmacy Practice, 2018, v. 31, n. 5, p. 481, doi. 10.1177/0897190017725984
    By:
    • Bell, Christine;
    • Anderson, James;
    • Ganguly, Tanmoy;
    • Prescott, James;
    • Capila, Ishan;
    • Lansing, Jonathan C.;
    • Sachleben, Richard;
    • Iyer, Mani;
    • Fier, Ian;
    • Roach, James;
    • Storey, Kristina;
    • Miller, Paul;
    • Hall, Steven;
    • Kantor, Daniel;
    • Greenberg, Benjamin M.;
    • Nair, Kavita;
    • Glajch, Joseph
    Publication type:
    Article
    15
    16
    17
    18
    19